Trials / Completed
CompletedNCT02818543
Safety and Pharmacokinetic Study of LYC-30937 in Subjects With Active Ulcerative Colitis
An Open-Label, Single Ascending Dose Study To Evaluate The Pharmacokinetic Profile, Safety and Tolerability of Orally Administered LYC-30937 in Subjects With Active Ulcerative Colitis
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 6 (actual)
- Sponsor
- Lycera Corp. · Industry
- Sex
- All
- Age
- 18 Years – 75 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study to assess the pharmacokinetic profile in patients with active ulcerative colitis and compare it to the experience in healthy volunteers.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | LYC-30937 |
Timeline
- Start date
- 2016-03-01
- Primary completion
- 2016-06-01
- Completion
- 2016-06-01
- First posted
- 2016-06-29
- Last updated
- 2016-12-14
Locations
2 sites across 1 country: Hungary
Source: ClinicalTrials.gov record NCT02818543. Inclusion in this directory is not an endorsement.